New technologies in diabetes mellitus management: from theory to practice

Cover Page

Cite item

Full Text

Abstract

At present time diabetes mellitus is one of the top-priority medical and social problems. The increased over the past 20 years diabetes mellitus incidence requires development not only of new treatment strategies but also of diagnostic methods. The number of endocrinologists' methods of glucose control constantly increases with new ones: new upgraded glucometers and continuous glucose monitoring systems. Considering that the measurement accuracy defines therapy choice and, therefore, degree of compensation of carbohydrate metabolism, it is quite important that patients' glucometers match the required standards. Insulin therapy with insulin pump is one of the most perspective treatment methods, its effectiveness has been repeatedly confirmed in clinical trials.

About the authors

I. A Barsukov

M.F.Vladimirskiy Moscow Regional Clinical Institute

Email: palantirr@inbox.ru
канд. мед. наук, ст. науч. сотр. отд-ния терапевтической эндокринологии 129110, Russian Federation, Moscow, ul. Shchepkina, d. 61/2

A. A Demina

M.F.Vladimirskiy Moscow Regional Clinical Institute

Email: annagalitskova@gmail.com
аспирант каф. эндокринологии ФУВ 129110, Russian Federation, Moscow, ul. Shchepkina, d. 61/2

References

  1. Глобальный доклад по диабету. ВОЗ, 2016.
  2. Tietz Fundamentals of Clinical Chemistry, 4th Edition. Editors Burtis and Ashwood. W.B. Saunders Company, 1996; p. 43-52.
  3. Diabetes Association. Diabetes and classification of diabetes mellitus. Diabetes care 2004; 27 (Suppl. 1): S5-S10.
  4. Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета [Электронный ресурс]: ГОСТ Р ИСО 15197-2015. Введ. 2016-06-01. http://docs.cntd.ru/document/1200120137. (Дата обращения 17.10.2017)
  5. Wahl P.W, Savage P.J, Psaty B.M et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998; 352: 1012-15.
  6. Древаль А.В., Мисникова И.В., Барсуков И.А. и др. Распространенность сахарного диабета 2 типа и ранних нарушений углеводного обмена среди взрослого населения Московской области. Ожирение и метаболизм. 2008; 2 (15): 11-6.
  7. Сахарный диабет 1 типа: реалии и перспективы. Под ред. И.И.Дедова, М.В.Шестаковой. М.: Мед. информ. агентство, 2016; с. 380-93.
  8. Pickup J.C, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002; 25: 593-8.
  9. Bode B.W, Sabbah H.T, Gross T.M et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S14-20.
  10. Pickup J, Mattock M, Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes. BMJ 2002; 324: 705-8.
  11. Hoogma R.P, Hammond P.J, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life. Diabet Med 2006; 23: 141-7.
  12. Rodriguеs A.S, Reid H.A, Ismail K et al. Indications and efficacy of continuоus subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med 2005; 22 (7): 842-9.
  13. American Diabetes Association. Standards of medical care in diabetes - 2017. Diabetes Care 2017; 40 (Suppl. 1): S1-S2.
  14. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю. Майорова. Вып. 8. М.: УП Принт, 2017.
  15. Древаль А.В., Барсуков И.А., Шестакова Т.П. и др. Помповая инсулинотерапия и непрерывное мониторирование гликемии: опыт клинической практики в рамках оказания высокотехнологичной медицинской помощи. РМЖ. 2017; 1: 3-8.
  16. Walsh J et al. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010; 4: 1174-81.
  17. Klonoff D.C. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-9.
  18. Древаль О.А. Непрерывное мониторирование гликемии в оценке эффективности лечения сахарного диабета. Автореф. дис.. канд. мед. наук. М., 2013.
  19. Dunne N., Viggiani M.T. Accuracy Evaluation of CONTOUR_PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6: 377-88.
  20. Baum J.M et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. Diab Tech Ther 2006; 8 (3): 347-57.
  21. Koschinsky T et al. Glucose monitoring at the arm - Risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002; 25: 956-60.
  22. Engelgau M.M, Narayan V, Herman W. Screening for type 2 diabetes. Diabetes care 2000; 23 (10): 1563-80.
  23. Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol 2003; 6 (2): 78-84.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies